NewLimit seeks a Scientist/Senior Scientist of In Vivo Pharmacology to lead in vivo studies evaluating epigenetic reprogramming therapeutics. You will design, execute, and interpret PK/PD, efficacy, and dose–response studies across disease models, collaborating with Epigenetic Editing and Predictive Modeling teams to advance candidates.
You will guide study design, CRO management, and data interpretation to inform preclinical decisions and support regulatory-enabling studies as programs progress
#J-18808-LjbffrSenior Scientist, In Vivo Pharmacology - Epigenetic Aging in south san francisco at Unknown Company
This position is listed as full time and onsite.